Our Healthcare team is a leading provider of cash flow based financing solutions primarily to private equity-backed, middle-market companies across a broad array of healthcare sectors.
Our borrowers typically have EBITDA between $5 million and $75 million.
Healthcare product offering lets us address each company’s unique needs with flexible structures and terms. Our partner-centered process provides substantive early feedback and a smooth transaction from start to finish.
The healthcare industry is highly complex, as the regulatory environment and payor and delivery models constantly evolve. NXT’s experienced team is dedicated to the space, maintaining a broad and deep understanding of each sector so we can provide fast, creative, reliable solutions to meet your financing needs.
For more information about NXT Capital’s healthcare financing solutions, contact us today.
Healthcare Sectors
- Providers
- Payors
- Outsourced services
- Healthcare IT
- Products
- Pharma
Transaction Types
- Leverage buyouts
- Refinancings
- Recapitalizations
- Add-on acquisitions
Financing Products
- Senior revolvers and term loans
- Stretch senior facilities
- Unitranche facilities
- Equity co-investments
As of 6/30/2024; Capital Under Management represents capital currently invested, available capital not currently invested, which is either based on a contractual capital commitment for the client or our understanding of the client’s capital commitment expectation for their program, and equity. Certain clients can unilaterally reduce or cancel their capital commitment, which would reduce the Capital Under Management shown above. Includes SMA and single investor programs ($4.5B), co-mingled funds ($2.1B), and invested capital or expected capital from parent, ORIX Corporation USA ($2.5B). NXT Capital was acquired by ORIX Corporation USA on 8/28/2018.